32 results
Disorders of the Hepatic and Mesenteric Circulation

Platelets in Cirrhosis
Hypercoagulability in Cirrhosis
Bleeding in Cirrhosis
Portal Vein Thrombosis (PVT)
Mesenteric
in Cirrhosis Bleeding ... Syndrome (BCS) ... Circulation #Disorders #Hepatology ... #Gastroenterology ... #diagnosis #Management
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Extremity Venous Thrombosis ... - Management and ... Superficial - Active Bleeding ... Superficial #Deep #VTE #DVT ... #Hematology #Management
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
Extremity Venous Thrombosis ... - Management and ... Veins #Venous #Thrombosis ... Superficial #Deep #VTE #DVT ... #Hematology #Management
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
for First Time DVT ... #DVT #Treatment ... #Algorithm #management ... #hematology #VTE ... #thrombosis #venous
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
points: Active bleeding ... @Clotmaster #Management ... #VTE #DVT #Algorithm ... Thromboembolism #Treatment #Hematology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Upper Extremity DVT ... Provoked first DVT ... syndrome - ... anticoagulation #duration #management ... #DVT #hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... catheter-related thrombosis ... without concomitant DVT ... Anticoagulation #Management ... #Hematology #Oncology
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Antiphospholipid Syndrome ... Antiphospholipid #Syndrome ... #APS #management ... EULAR2019 #guidelines #rheumatology ... #hematology #treatment
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Breakthrough/Extension of Thrombosis ... and Management ... #Breakthrough #Thrombosis ... Extension #VTE #DVT ... #Hematology #Management
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
cancer-associated thrombosis ... DVT = deep vein ... thrombosis; PE = ... Anticoagulation #Management ... #Hematology #Oncology